RESEARCH · CLAIMS GOVERNANCE
Claims Substantiation Sheet
Exact wording, sources, evidence strength, approved use, and required qualifications for outreach-sensitive statements across the Pure Path ecosystem.
How to use this sheet: Before pitching journalists or updating ads, find the claim ID, check Approved use, and prefer Approved wording. Items marked Revise / remove or Unverified must not lead Wave 1 outreach. This page is intentionally public so publishers can see how the brand governs language.
Scope
Properties covered: purepathnorthwest.com, getppnw.com, ppnwadvisor.com, and founder materials on dannyalbert.com where claims overlap. Strength labels are editorial risk ratings, not legal opinions.
Strength legend
- Strong — Directly verifiable product/software fact or well-established basic science with clear scope.
- Moderate — Plausible mechanism or policy with incomplete public primary docs or not product-RCT proven.
- Weak — Extrapolation, thin citation chain, or anecdote-shaped.
- Unverified — Specific number or market % not locked to a named primary source in-house.
- Marketing-only — Rhetorical homepage/story language; not for press as fact.
Master table
| Claim | Exact public wording | Location | Source / citation status | Study type | Applies to our product? | Strength | Approved use | Approved wording | Required disclaimer / action |
|---|---|---|---|---|---|---|---|---|---|
| 5x bioavailability ID: bioavail-5x |
B12 absorption increases 3–5x baseline (critical if on Metformin) | ppnwadvisor advisor copy; related stack-amplification language across Path | Secondary summaries of chelation/transport literature on humic substances and mineral uptake. No Pure Path–branded human RCT on file in this sheet. | Lab / secondary review of carrier-molecule literature (not product-specific RCT) | No — not demonstrated on Pure Path finished lots in a controlled human trial | Weak | Editorial (qualified) | Some laboratory and secondary sources describe improved mineral uptake when fulvic-type carriers are present. Absorption multiples vary by mineral, form, dose, and study design. Pure Path has not published a product-specific human bioavailability RCT. | Do not state a guaranteed 5x outcome for customers. Prefer “may support delivery” + cite mechanism pages. |
| 4–12x mineral absorption ID: bioavail-4-12x |
increases nutrient absorption 4-12x baseline / Amplifies nutrient absorption 4-12x baseline | ppnwadvisor web/index.html FAQ schema; shop_screen.dart; advisor_service.dart; vector_prompt.dart | Marketing synthesis referencing chelation-mediated transport ranges across minerals. Needs primary citation lock before outreach. | Mixed lab / review language; range appears promotional without pinned primary paper in public library | No | Unverified | Revise / remove | Fulvic acids are studied as chelating carriers that can influence mineral solubility and membrane interaction. Quantified “X times absorption” figures should only be used when a named primary study, population, and mineral are cited. | Remove bare 4–12x claims from customer-facing Path copy before Wave 1 publisher outreach. |
| 99% of fulvic products are “dead dirt” ID: dead-dirt-99 |
Why 99% of Fulvic Products Are Dead Dirt | purepathnorthwest homepage reveal Card 09 | Rhetorical framing tied to heat/chemical processing concerns and category variance narratives (e.g., third-party testing variance stories). Not a census of all retail SKUs. | Marketing narrative / category quality commentary | N/A (market claim) | Marketing-only | Revise / remove | Heat and aggressive chemical processing can degrade functional groups important to humic-substance behavior. Product quality in this category varies widely; consumers should request extraction method, source disclosure, and contaminant testing. | Do not use “99%” as a factual statistic in press materials or outreach. |
| 32,000% variance in fulvic content ID: variance-32000 |
VARIANCE 32,000% / ConsumerLab 32,000% variance report (38 products) | purepathnorthwest homepage receipt line; ppnwadvisor advisor_service.dart | Referenced as ConsumerLab-style independent testing narrative in Path advisor copy. Confirm exact report title, year, and metric definition before citing externally. | Third-party commercial testing (if confirmed) vs. internal retelling | No — category testing claim | Moderate | Editorial (qualified) | Independent testing of commercial fulvic products has been reported to show extreme variance in measured active content across brands. Cite the specific report name, date, sample size, and method when used publicly. | Do not imply Pure Path was the tester. Link or name the independent source when verified. |
| 80% of shilajit is fake / heavily contaminated framing ID: shilajit-fake-80 |
contamination risk language on Pure Path vs Shilajit and related education | purepathnorthwest /vs/shilajit and science explainers | Category quality concerns are widely discussed; a precise “80% fake” figure is not locked to a primary public citation in this sheet. | Market quality commentary | N/A | Unverified | Revise / remove | Shilajit is a crude resin that may contain fulvic fractions plus other geological material. Contaminant and authenticity issues have been reported in the category; buyers should demand identity testing and heavy-metal panels. | Avoid percentage-of-market fraud claims without a named audit. |
| Heavy-metal binding / escort / detox pathways ID: heavy-metal-binding |
binds heavy metals and toxins in the gut and escorts them out; continuous heavy-metal escort; detoxification processes | content.ts humic science, product humic PDP, protocols, personas (welders/mechanics) | Peer-reviewed literature on humic substances and metal complexation in environmental/aqueous systems; gut-lumen binder analogy is mechanistic education, not a disease-treatment claim. | Lab / environmental chemistry + mechanistic analogy; limited product-specific human detox trials | Batch heavy-metal *content* testing ≠ clinical detox efficacy trial | Moderate | Editorial (qualified) | Humic fractions have documented affinity for certain metal cations in chemical systems. Pure Path discusses gut-lumen binding support as a mechanistic concept. This is not a proven medical detoxification treatment and is not intended to diagnose, treat, cure, or prevent disease. | Strip disease and “toxin removal guarantee” language from outreach. Prefer binding/complexation wording. |
| Mitochondrial respiration / cellular energy via fulvic mineral delivery ID: mitochondrial-respiration |
Transport to the mitochondrial level is the relevant endpoint; minerals for ATP production | /science/mitochondrial-respiration and related protocols | Established mineral cofactor roles in mitochondrial enzymes (general biochemistry) + fulvic-as-carrier hypothesis. No Pure Path ATP clinical endpoint study in this sheet. | Biochemistry textbook-level cofactor science + carrier hypothesis | No direct product ATP trial | Moderate | Editorial (qualified) | Mitochondria require mineral cofactors for normal energy metabolism. If fulvic materials improve delivery of those minerals in a given context, energy pathways could be indirectly supported. Pure Path does not claim a measured increase in mitochondrial respiration from its finished products in human trials. | No “boosts mitochondria” guarantee. No disease/fatigue treatment claims. |
| Peptide performance amplification ID: peptide-performance |
stack amplification / peptides absorb instead of passing through | Product Q&A and Path advisor longevity/stack language | Extrapolation from carrier-molecule framing; weak direct peptide clinical evidence in public sheet | Hypothesis / marketing extension | No | Weak | Internal only | Some users include fulvic materials alongside broader supplement stacks. Peptide-specific absorption multiples are not established for Pure Path products in controlled trials. | Do not lead outreach with peptide performance claims. |
| Cold-water / cold extraction preserves functional groups ID: cold-extraction |
Cold-water extraction protects active molecular behavior; 400-day cold extraction (Path) | Science pages, products, Path advisor (Ponomareva narrative) | Extraction-chemistry rationale + cited study narratives in Path copy. Confirm primary citation details before press use of “400-day” and percentage preservation figures. | Process chemistry / cited extraction comparison narratives | Process claim for Pure Path method — document SOPs and lot records for journalists | Moderate | Sales (qualified) | Pure Path uses cold-extraction process standards intended to preserve carboxyl and phenolic functional groups associated with humic-substance behavior. Heat and harsh chemical processing can degrade those groups. Process details and lot testing are available to qualified press on request. | Pair with testing transparency; avoid implying all heat-processed products are inert without nuance. |
| Every batch independently tested for heavy metals and potency ID: third-party-hm-testing |
Every Pure Path batch is independently tested for heavy metals and potency | Science/QA copy, ecosystem pages, Momentous comparison Q&A | Company quality-control policy. Publishable COAs strengthen this to Strong. | Company QC + third-party lab panels (when COA attached) | Yes — when lot COA is produced | Moderate | Sales (qualified) | Pure Path states that finished lots are third-party tested for heavy metals and potency. Request the lot-matched Certificate of Analysis for the SKU and date in question. | Do not claim NSF/USP certification unless held. Offer COA on request or public library when files are cleared. |
| Utah / domestic auditable humate source ID: utah-source |
Utah source deposit; domestic (Utah, USA) humate deposits | Ecosystem and journal sourcing copy | Company supply-chain disclosure | Supply-chain attestation | Yes (source claim) | Moderate | Sales (qualified) | Pure Path discloses domestic (Utah, USA) humate sourcing with an auditable chain of custody relative to opaque import-only resins. Ask for current source documentation for press verification. | Keep geographic claims consistent across properties. |
| Fulvic and humic sold separately (not blended) ID: separated-fulvic-humic |
we separate them so binding support does not compete with nutrient-transport | Product mechanism copy, vs fulvic-vs-humic | Product architecture (SKU design) — verifiable by label/shop | Product design fact | Yes | Strong | Sales (qualified) | Pure Path sells fulvic acid powder and humic acid powder as separate SKUs so delivery-oriented and binding-oriented use can be timed independently (e.g., AM/PM protocols). | Educational separation rationale is fine; avoid disease claims. |
| Implied health outcomes (energy, recovery, clarity, labs rising) ID: health-outcomes |
stubbornly low D3 finally climb; recovery markers; brain fog framing | Path advisor copy; persona pages; protocol pages | Anecdotal / educational scenarios — not controlled outcomes research on Pure Path SKUs | Anecdote / hypothesis | No clinical endpoints on file here | Weak | Internal only | Individuals may track subjective markers (energy, sleep, clarity) while using a protocol. Results vary. Products are dietary supplements, not treatments. | FDA disclaimer required. No diagnose/treat/cure/prevent language in outreach. |
| Path AI Health Advisor capabilities ID: path-ai-function |
personalized guidance and tracking / AI-assisted health tracking | ppnwadvisor.com product positioning | Product behavior (app features) | Verified product description when matched to shipped features | Yes (software) | Strong | Sales (qualified) | Path AI Health Advisor is a software tool for educational guidance and self-tracking related to fulvic/humic protocols. It does not provide medical diagnosis or treatment. | Always pair with medical disclaimer; no clinician replacement claims. |
Priority remediation (before Phase 3 outreach)
- Retire bare 4–12× and guaranteed 5× absorption lines on Path web/app surfaces or replace with approved wording + named citations.
- Replace homepage 99% dead dirt factual implication with process-variance language.
- Confirm and file the independent variance report if 32,000% language continues in education.
- Publish or link lot-matched COAs to upgrade third-party testing claims from policy to document-backed.
- Keep heavy-metal language in binding/complexation frame; avoid medical detox treatment claims in pitches.
- Path AI: describe features accurately; never as diagnosis/treatment.
Standard footer for educational pages
These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Occupational and recovery discussions are educational and are not medical care plans.
Change log
- 2026-03-29 — v1.0: Initial public sheet created from live site/app claim audit (homepage reveal cards, science library, Path advisor/shop copy).